ERLOTINIB ZENTIVA 100 mg, comprimé pelliculé sécable — plaquettes OPA : polyamide orienté aluminium PVC-Aluminium de 30 comprimés

Medicine package · Base de données publique des médicaments (BDPM), ANSM, HAS et Assurance Maladie · France

  • CIP13 3400930187555
  • CIP7 3018755
  • CIS 66900121

What the source publishes

Holder
ZENTIVA FRANCE
Active ingredients
CHLORHYDRATE D'ERLOTINIB, ERLOTINIB
Form
comprimé pelliculé sécable
Package
plaquettes OPA : polyamide orienté aluminium PVC-Aluminium de 30 comprimés
Routes
orale
Administrative status
authorised
Supply regime
médicament nécessitant une surveillance particulière pendant le traitement ; prescription réservée aux spécialistes et services ONCOLOGIE MEDICALE ; prescription réservée aux spécialistes et services HEMATOLOGIE ; prescription hospitalière ; liste I ; prescription réservée aux médecins compétents en CANCEROLOGIE
Marketing status
Déclaration de commercialisation
Authorised on
2019-07-31
Prescription
Prescription or restricted

Names this record is found by

Complete source data
fr:ansm:packages:3400930187555
{
  "cis": "66900121",
  "cip7": "3018755",
  "form": "comprimé pelliculé sécable",
  "name": "ERLOTINIB ZENTIVA 100 mg, comprimé pelliculé sécable — plaquettes OPA : polyamide orienté aluminium PVC-Aluminium de 30 comprimés",
  "cip13": "3400930187555",
  "holder": "ZENTIVA FRANCE",
  "routes": [
    "orale"
  ],
  "holders": [
    "ZENTIVA FRANCE"
  ],
  "currency": "EUR",
  "marketed": true,
  "bdmStatus": null,
  "useDomain": "unknown",
  "publicPrice": "695.72",
  "authorisedOn": "2019-07-31",
  "compositions": [
    {
      "name": "CHLORHYDRATE D'ERLOTINIB",
      "nature": "SA",
      "strength": null,
      "linkageNumber": "1",
      "substanceCode": "27387",
      "dosageReference": null,
      "pharmaceuticalElement": "comprimé"
    },
    {
      "name": "ERLOTINIB",
      "nature": "FT",
      "strength": "100 mg",
      "linkageNumber": "1",
      "substanceCode": "56421",
      "dosageReference": "un comprimé",
      "pharmaceuticalElement": "comprimé"
    }
  ],
  "sourceStatus": "Présentation active",
  "supplyRegime": "médicament nécessitant une surveillance particulière pendant le traitement ; prescription réservée aux spécialistes et services ONCOLOGIE MEDICALE ; prescription réservée aux spécialistes et services HEMATOLOGIE ; prescription hospitalière ; liste I ; prescription réservée aux médecins compétents en CANCEROLOGIE",
  "dispensingFee": "1.02",
  "medicinePrice": "694.70",
  "regionalRules": "not-collected",
  "targetSpecies": [],
  "specialityName": "ERLOTINIB ZENTIVA 100 mg, comprimé pelliculé sécable",
  "marketingStatus": "Déclaration de commercialisation",
  "publicationDates": {
    "CIS_bdpm": "2026-01-08",
    "CIS_CIP_bdpm": "2026-11-19",
    "CIS_CPD_bdpm": "2026-01-08",
    "CIS_COMPO_bdpm": "2026-01-08"
  },
  "specialityListed": true,
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "fr.ansm.bdpm"
  },
  "collectiveApproval": "oui",
  "packageDescription": "plaquettes OPA : polyamide orienté aluminium PVC-Aluminium de 30 comprimés",
  "patientEligibility": "not-assessed",
  "reimbursementRates": [
    "100 %"
  ],
  "marketingDeclaredOn": "2020-03-23",
  "targetSpeciesStatus": "not-reported",
  "additionalMonitoring": false,
  "administrativeStatus": "authorised",
  "prescriptionCategory": "prescription-or-restricted",
  "activeIngredientNames": [
    "CHLORHYDRATE D'ERLOTINIB",
    "ERLOTINIB"
  ],
  "authorisationProcedure": "Procédure de reconnaissance mutuelle",
  "prescriptionConditions": [
    "médicament nécessitant une surveillance particulière pendant le traitement",
    "prescription réservée aux spécialistes et services ONCOLOGIE MEDICALE",
    "prescription réservée aux spécialistes et services HEMATOLOGIE",
    "prescription hospitalière",
    "liste I",
    "prescription réservée aux médecins compétents en CANCEROLOGIE"
  ],
  "reimbursementIndications": null,
  "authorisationSourceStatus": "Autorisation active",
  "europeanAuthorisationNumber": null,
  "presentationAdministrativeStatus": "authorised"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=fr" \
  --data-urlencode "sourceId=fr.ansm.bdpm" \
  --data-urlencode "id=fr:ansm:packages:3400930187555"